Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Switzerland Tech Review.
Press releases published on May 12, 2025
Unlocking ROI in IT Investments: Xraised Interviews Alexandre Gay, Founder of BG&A
EIN Presswire
·
May 12, 2025
GENEVA, SWITZERLAND, May 12, 2025 /EINPresswire.com/ -- 🔗 Discover the full interview on Xraised 🔗 Explore BG…
TAVA Founding Board Members to Represent Swiss & European Innovation at 2025 SelectUSA Investment Summit
EIN Presswire
·
May 12, 2025
Nonprofit accelerator set to debut in June; first cohort of Swiss tech companies arrives this fall for intensive U.S. market entry program WASHINGTON, DC, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- Founding board members of the Transatlantic …
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
May 12, 2025
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody® sonelokimab across portfolio of indications, including Phase 3 studies in …
SONEXOS APPOINTS ANDREA ONETTI AS CHIEF OPERATING OFFICER TO LEAD GLOBAL OPERATIONS & COMMERCIALIZATION OF PLASMAPANEL
EIN Presswire
·
May 12, 2025
Respected Leader in Audio Electronics to Drive Market Expansion of Sonexos’ AI-Driven Solid-State Active Noise Control Solutions LAUSANNE, VAUD, SWITZERLAND, May 12, 2025 /EINPresswire.com/ -- Sonexos, a pioneer in solid-state active noise control …
STMicroelectronics Announces Status of Common Share Repurchase Program
GlobeNewswire
·
May 12, 2025
STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from May 5, 2025 to May 9, 2025 AMSTERDAM – May 12, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global …
Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies
GlobeNewswire
·
May 12, 2025
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 12, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for …